IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

FATTIZZO, BRUNO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 17.641
AS - Asia 13.029
NA - Nord America 12.739
SA - Sud America 1.987
AF - Africa 422
OC - Oceania 151
Continente sconosciuto - Info sul continente non disponibili 12
Totale 45.981
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.653
DE - Germania 8.159
CN - Cina 3.735
IT - Italia 3.205
SG - Singapore 3.170
GB - Regno Unito 1.452
BD - Bangladesh 1.217
BR - Brasile 1.128
HK - Hong Kong 1.004
FR - Francia 928
VN - Vietnam 909
IN - India 850
RU - Federazione Russa 754
JP - Giappone 629
ES - Italia 566
SE - Svezia 533
MX - Messico 507
CA - Canada 471
ID - Indonesia 399
NL - Olanda 386
IE - Irlanda 312
TR - Turchia 272
AR - Argentina 256
FI - Finlandia 256
CO - Colombia 217
CH - Svizzera 151
GR - Grecia 144
PL - Polonia 132
AU - Australia 126
KR - Corea 122
CI - Costa d'Avorio 117
CL - Cile 110
PE - Perù 101
BE - Belgio 97
PK - Pakistan 92
TH - Thailandia 82
DK - Danimarca 81
AT - Austria 78
EC - Ecuador 75
UA - Ucraina 70
ZA - Sudafrica 62
SA - Arabia Saudita 61
PT - Portogallo 60
TW - Taiwan 59
PH - Filippine 57
EG - Egitto 55
RO - Romania 52
MY - Malesia 51
IR - Iran 50
IQ - Iraq 44
IL - Israele 42
NO - Norvegia 40
MA - Marocco 39
DZ - Algeria 38
HR - Croazia 35
VE - Venezuela 33
UY - Uruguay 26
NZ - Nuova Zelanda 25
AE - Emirati Arabi Uniti 23
BO - Bolivia 23
TN - Tunisia 23
RS - Serbia 22
AL - Albania 21
HU - Ungheria 21
UZ - Uzbekistan 20
JO - Giordania 19
LB - Libano 18
PY - Paraguay 18
CR - Costa Rica 17
LU - Lussemburgo 14
JM - Giamaica 13
KE - Kenya 13
LT - Lituania 13
OM - Oman 13
BG - Bulgaria 11
CZ - Repubblica Ceca 11
NP - Nepal 11
GT - Guatemala 10
PA - Panama 10
LK - Sri Lanka 9
SI - Slovenia 9
SN - Senegal 9
AO - Angola 8
HN - Honduras 8
MN - Mongolia 8
PR - Porto Rico 8
EE - Estonia 7
ET - Etiopia 7
QA - Qatar 7
AZ - Azerbaigian 6
CU - Cuba 6
CY - Cipro 6
GD - Grenada 6
KW - Kuwait 6
LV - Lettonia 6
LY - Libia 6
MD - Moldavia 6
PS - Palestinian Territory 6
SK - Slovacchia (Repubblica Slovacca) 6
TT - Trinidad e Tobago 6
Totale 45.865
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 6.645
Singapore 1.678
Ashburn 1.435
Hanover 930
Hong Kong 827
Dallas 769
Southend 758
Milan 731
San Jose 603
Chandler 585
Beijing 504
New York 484
Council Bluffs 469
Santa Clara 400
Los Angeles 375
Rome 316
Dublin 303
Ho Chi Minh City 291
Princeton 291
Hefei 271
Fairfield 269
Shanghai 225
Hanoi 218
Wilmington 217
Seattle 196
Bengaluru 195
Lauterbourg 195
Helsinki 192
Buffalo 189
Tokyo 175
Jakarta 174
Redwood City 168
São Paulo 166
Madrid 164
Cambridge 150
Guangzhou 144
Houston 144
Moscow 139
Woodbridge 139
Toronto 127
Paris 124
Des Moines 119
Abidjan 117
Tianjin 112
Ann Arbor 110
Naples 110
Chicago 106
Boardman 105
Hyderabad 104
Istanbul 103
Buenos Aires 101
Bogotá 95
London 95
Nanjing 95
Hangzhou 86
Barcelona 81
Mexico City 81
Columbus 78
Phoenix 77
Berlin 73
Chennai 71
Lima 70
Santiago 69
Turin 69
Boston 68
Manchester 67
Seoul 66
Amsterdam 65
Genoa 65
Munich 62
Bologna 59
Montreal 58
The Dalles 58
Chengdu 57
Dearborn 57
Brooklyn 56
New Delhi 56
Atlanta 55
Florence 53
Cangzhou 52
Shenzhen 52
Brussels 51
Rio de Janeiro 51
Zurich 51
Athens 50
Da Nang 50
Vienna 50
Washington 49
Verona 48
Jinan 47
Bangkok 46
Bari 46
Osaka 46
Warsaw 46
Mumbai 45
Belo Horizonte 44
Duncan 44
Nuremberg 43
Palermo 42
Medellín 41
Totale 26.398
Salva come PNG Salva come JPEG
Nome #
How I treat warm autoimmune hemolytic anemia 4.620
Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia : a GIMEMA study of 308 Patients 1.929
Predictors of refractoriness to therapy and healthcare resource utilization in 378 patients with primary autoimmune hemolytic anemia from eight Italian reference centers 1.524
Short course of bortezomib in anemic patients with relapsed cold agglutinin disease : a phase 2 prospective GIMEMA study 720
Anemia emolitica autoimmune dall’approccio classico ai nuovi farmaci 586
Low-dose rituximab in autoimmune hemolytic anemia : 10 years after 518
Complement inhibition in paroxysmal nocturnal hemoglobinuria: From biology to therapy 503
Concomitant Occurrence of Blastic Plasmacytoid Dendritic Cell Neoplasm and Acute Myeloid Leukaemia after Lenalidomide Treatment for del(5q) Myelodysplastic Syndrome 497
Circulating extracellular vesicles and cytokines in congenital and acquired hemolytic anemias 433
Evidence based use of erytrhopoietin in patients with autoimmune hemolytic anemia: a multicenter international study 419
Iron mobilization in a real life cohort of aplastic anemia patients treated with eltrombopag 404
Prognostic and predictive impact of small PNH clones in a large cohort of patients with myelodysplastic syndrome and aplastic anemia: a single-center experience 392
Safety and efficacy of pegcetacoplan treatment for cold agglutinin disease and warm antibody autoimmune hemolytic anemia 372
Seasonal variation in the incidence of cold agglutinin disease in Norway, Denmark, and Italy 360
Management of refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation : current perspectives 352
Ensuring continuity of care of hematologic patients during COVID-19 pandemic in a tertiary hospital in Lombardy (Italy) 344
Clinical and morphological predictors of outcome in older aplastic anemia patients treated with eltrombopag 316
Paroxysmal Nocturnal Hemoglobinuria (Pnh) : Brain Mri Ischemic Lesions in Neurologically Asymtomatic Patients 310
Autoimmune Cytopenias in Chronic Lymphocytic Leukemia: Focus on Molecular Aspects 302
Clinical and Morphologic Predictors of Outcome in a Multicenter Cohort of ITP Patients Treated with Trombopoietin Analogues 298
Co-Occurrence of Myeloid and Lymphoid Neoplasms: Clinical Characterization and Impact on Outcome. A Single-Center Cohort Study 292
Biological and molecular characterization of a rare case of cutaneous Richter syndrome 283
IgA hypogammaglobulinemia predicts outcome in chronic lymphocytic leukemia 273
Luspatercept in combination with recombinant erythropoietin in patients with myelodysplastic syndrome with ring sideroblasts: Stimulating early and late‐stage erythropoiesis 272
Multifactorial neutropenia in a patient with acute promyelocytic leukemia and associated large granular lymphocyte expansion: A case report 268
Off-Label Use of Thrombopoietin Receptor Agonists: Case Series and Review of the Literature 263
Low-Risk Myelodysplastic Syndrome Revisited: Morphological, Autoimmune, and Molecular Features as Predictors of Outcome in a Single Center Experience 261
Evans syndrome in adults : an observational multicenter study 257
Glycolytic activity and in vitro effect of the pyruvate kinase activator AG‐946 in red blood cells from low‐risk myelodysplastic syndromes patients: A proof‐of‐concept study 253
Predictors of atrial fibrillation in ibrutinib-treated CLL patients : a prospective study 253
Bone marrow characteristics predict outcome in a multicenter cohort of primary immune thrombocytopenia patients treated with thrombopoietin analogs 249
Transfusions in autoimmune hemolytic anemias: Frequency and clinical significance of alloimmunization 248
Impact of bone marrow fibrosis in response to azacitidine in 94 patients with myelodisplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia 248
Clinical significance of PNH clones in 3085 patients with cytopenia: a large single-center experience 246
Large Granular Lymphocyte Expansion in Myeloid Diseases and Bone Marrow Failure Syndromes : Whoever Seeks Finds 243
Clinical and prognostic significance of small paroxysmal nocturnal hemoglobinuria clones in myelodysplastic syndrome and aplastic anemia 242
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) role in hematopoiesis and in hematologic diseases: A critical review 241
Mesenchymal Stem Cells in Myeloid Malignancies: A Focus on Immune Escaping and Therapeutic Implications 241
Impact of Bone Marrow Fibrosis and Early Response on Outcome after Azacitidine Therapy in 94 Patients with Myelodisplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia 241
Chronic Idiopathic Neutropenia In Adults: Clinical Features In a 4-Year Prospective Study 241
Complement Mediated Hemolytic Anemias in the COVID-19 Era : Case Series and Review of the Literature 240
Reduced expression of toll-like receptor 4 in B-chronic lymphocytic leukemia patients with autoimmune complications 239
Small Paroxysmal Nocturnal Hemoglobinuria Clones in Autoimmune Hemolytic Anemia: Clinical Implications and Different Cytokine Patterns in Positive and Negative Patients 238
Real‐world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts 236
Comprehensive Biological and Molecular Characterization of a RARE Case of Cutaneous Richter Syndrome 235
Eltrombopag in Immune Thrombocytopenia, Aplastic Anemia, and Myelodysplastic Syndrome : From Megakaryopoiesis to Immunomodulation 230
The Physiopathology of T- Cell Acute Lymphoblastic Leukemia: Focus on Molecular Aspects 229
Bone Marrow Fibrosis and Early Hematological Response as Predictors of Poor Outcome in Azacitidine Treated High Risk-Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia 229
The Immunomodulatory Effect and Clinical Efficacy of Daratumumab in a Patient With Cold Agglutinin Disease 229
Efficacy of recombinant erythropoietin in autoimmune haemolytic anaemia: a multicentre international study 226
Bortezomib in autoimmune hemolytic anemia and beyond 226
Brain MRI Findings and Neuro-Psychiatric Involvement in Paroxysmal Nocturnal Hemoglobinuria (PNH) 223
Autoimmune hemolytic anemia: clinical severity and laboratory heterogeneity in 157 patients 221
The Changing Landscape of Autoimmune Hemolytic Anemia 217
Hypoplastic myelodysplastic syndromes: Just an overlap syndrome? 217
Evidence based use of erytrhopoietin in patients with Autoimmune Hemolytic Anemia : a multicenter international study 215
Treating chronic lymphocytic leukemia with obinutuzumab: safety and efficacy considerations 213
Myelofibrosis and following chronic myeloid leukemia: imatinib and ruxolitinib treatment in two cases 212
Confounding factors in the diagnosis and clinical course of rare congenital hemolytic anemias 212
Neuro-psychiatric involvement in paroxysmal nocturnal hemoglobinuria (PNH) 210
Rise of the planet of rare anemias: An update on emerging treatment strategies 209
Toll-like receptor 4 and 9 expression in B-chronic lymphocytic leukemia: relationship with infections, autoimmunity and disease progression 208
Iron overload in congenital haemolytic anaemias: role of hepcidin and cytokines and predictive value of ferritin and transferrin saturation 208
Clinical Applications of Hemolytic Markers in the Differential Diagnosis and Management of Hemolytic Anemia 207
Inhibition of C3 with APL-2 controls haemolysis and increases haemoglobin levels in subjects with Autoimmune Haemolytic Anaemia (AIHA) 207
Innovative Treatments for Rare Anemias 207
25-Oh Vitamin D, Vitamin D Receptor and Immunomodulatory Cytokines Serum Levels in Patients with Autoimmune Citopenias: Correlation with Hematologic Parameters and Clinical Severity 204
Three hematologic malignancies in the same patient : chronic lymphocytic leukemia, followed by chronic myeloid leukemia and acute myeloid leukemia 203
Switching to an alternative recombinant erythropoietin agent in patients with myelodysplastic syndromes : a second honeymoon? 203
Second-line administration of thrombopoietin receptor agonists in immune thrombocytopenia: Italian Delphi-based consensus recommendations 203
Mesenchymal Stem Cells in Aplastic Anemia and Myelodysplastic Syndromes: The "Seed and Soil" Crosstalk 202
Idelalisib rapidly improves platelet function tests in patients with chronic lymphocytic leukaemia 202
Infectious and thrombotic complications and their prognostic impact in patients with concomitant myeloid and lymphoid neoplasms : a single-center cohort study 202
Prognostic impact of bone marrow fibrosis and dyserythropoiesis in autoimmune hemolytic anemia 201
Is chronic neutropenia always a benign disease? Evidences from a 5-year prospective study 200
Clinical heterogeneity of autoimmune hemolytic anemia: a gimema study of 308 patients 199
Anti-erythroblast autoimmunity in early myelodysplastic syndromes: enhancement of EPO/EPO-R system and PRO-apoptotic effect 199
Recent insights into the role of the microbiome in malignant and benign hematologic diseases 199
Evans syndrome: Disease awareness and clinical management in a nation‐wide ITP‐NET survey 198
Reply to “COVID-19 in persons with haematological cancers”: a focus on myeloid neoplasms and risk factors for mortality 198
Efficacy and safety of cyclosporine A treatment in autoimmune cytopenias: the experience of two Italian reference centers 197
Lessons from very severe, refractory, and fatal primary autoimmune hemolytic anemias 196
Clinical follow-up of 378 patients with autoimmune hemolytic anemia: prognostic impact of hemoglobin levels, autoantibody class, and reticulocytopenia at onset on the relapse risk and outcome 196
Prevalence and clinical significance of small PNH clones in patiens with primary autoimmune hemolytic anemia 194
Moving toward Individual Treatment Goals with Pegcetacoplan in Patients with PNH and Impaired Bone Marrow Function 193
Autoimmune hemolytic anemia in adults: primary risk factors and diagnostic procedures 193
Infectious complications in autoimmune hemolytic anemia 193
Deciphering cytopenias in internal medicine: a single-center observational study 188
Impact of intravascular hemolysis and multitreatment on thrombosis occurrence in autoimmune hemolytic anemia 188
Reduced 25-OH vitamin D in patients with autoimmune cytopenias, clinical correlations and literature review 183
A case of chronic chronic lymphocytic leukemia developing chronic myeloid leukemia with high platelets and followed by acute myeloid leukemia 183
Difficult cases of paroxysmal nocturnal hemoglobinuria: Diagnosis and therapeutic novelties 183
Paroxysmal Nocturnal Hemoglobinuria in the Context of a Myeloproliferative Neoplasm: A Case Report and Review of the Literature 183
Idelalisib Rapidly Improves Platelets Function in Patients with Chronic Lymphocytic Leukemia (CLL) 182
Autoimmune Hemolytic Anemia as a Complication of Congenital Anemias. A Case Series and Review of the Literature 182
Atrial Fibrillation (AF) and Ibrutinib, a Monocentric Experience: Should Cardiological Evaluation be a Guide in Clinical Practice? 182
Danazol Treatment for Thrombocytopenia in Myelodysplastic Syndromes: Can an "Old-fashioned" Drug be Effective? 181
Androgen use in bone marrow failures and myeloid neoplasms: Mechanisms of action and a systematic review of clinical data 181
Hypogammaglobulinemia in Chronic Lymphocytic Leukemia: A Predictor of Outcome? 180
Clinical Heterogeneity Of Autoimmune Hemolytic Anemia: A 35-Years Retrospective Study Of 157 Patients 180
Totale 32.608
Salva come PNG Salva come JPEG
Categoria #
all - tutte 104.623
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.623
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.631 112 154 299 221 283 200 229 455 468 357 340 513
2022/20234.063 379 310 299 384 294 548 280 301 428 175 395 270
2023/20248.022 266 276 275 323 589 297 1.108 969 580 983 1.247 1.109
2024/20259.443 1.003 1.196 862 959 498 422 415 654 569 656 681 1.528
2025/202617.603 1.413 1.185 1.938 1.452 1.330 896 1.929 826 1.558 1.044 1.972 2.060
2026/2027864 864 0 0 0 0 0 0 0 0 0 0 0
Totale 47.151